Investigation of occult hepatitis B infection in blood donors in Panyu District, Guangzhou
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 10
Abstract
Objective To investigate the status of occult hepatitis B virus infection (OBI) among blood donors in Panyu District of Guangzhou, so as to provide reference for blood transfusion safety. Methods From January 1, 2021 to July 31, 2023, 60 872 blood donors in Panyu District with HBsAg-/HBV DNA+ were screened as OBI subjects. The age, gender and frequency of blood donation of OBI donors were statistically analyzed. HBV DNA viral load was detected and hepatitis B five-panel test was performed. Results The HBsAg-/HBV DNA+positive rate of blood donors in Panyu District was 0.08% (50/60 872). The OBI positive rate of male blood donors was higher than that of female blood donors, with no statistically significant difference(P>0.05). The OBI positive rate of blood donors increased with age, with statistically significant difference(P<0.05). The OBI positive rate of first-time blood donors was higher than that of repeat blood donors, with statistically significant difference(P<0.05). Of the 50 HBsAg-/HBV DNA+ donors, 42 had a follow-up test, among which 14 had no HBV DNA detected. The mean value of the initial screening resolution CT was 37.77. In hepatitis B five-panel test, single HBsAb+ accounted for the highest proportion as 50% (7/14). HBV DNA viral load was detected in 28 cases, and viral load <10 IU/mL accounted for 50%(14/28) and that <200 IU/mL accounted for 96% (27/28). The mean value of initial screening resolution CT was 34.55, mainly HBeAb+/HBcAb+ in hepatitis B five-panel test, accounting for 32.14% (9/28). After multiple follow-up of 24 blood donors, 37.5% (9/24) were detected with viral load, 33.33% (8/24) were detected with no viral load, and 29.17% (7/24) had both negative and positive results. The hepatitis B five-panel test outcome of 29.17% (7/24) donors showed a turnover, while 70.83% (17/24) did not. Conclusion The OBI positive rate is lower in young repeat blood donors. Since OBI is the result of a variety of complex mechanisms, and the existing serological NAT cannot detect all OBI donors, strict pre-donation consultation and screening of previous HBV DNA+ donors are very important for blood safety. It is recommended that patients with weakened immunity, such as organ transplantation, tumor chemoradiotherapy, or the use of immunosuppressive drugs, use virus inactivated blood products.
Authors and Affiliations
Pingping CHEN, Wenli LAN, Feifang HONG, Weiwen MA
Keywords
Related Articles
- EP ID EP749838
- DOI 10.13303/j.cjbt.issn.1004-549x.2024.10.009
- Views 38
- Downloads 0
Analysis of monitoring results of novel coronavirus IgM and IgG antibody levels in apheresis platelets donors and impact on blood safety
Objective To monitor the positive rates of IgM and IgG antibodies and the changes in S/CO values over time in voluntary blood donors infected with SARS-CoV-2 after recovery, in order to provide theoretical basis and data...
Chinese expert consensus on standardized application of automation technology for transfusion compatibility testing
Given the increasingly widespread application of automation technology in transfusion compatibility testing, in order to reduce the systemic and hidden risks of automated testing equipment, to provide guidance for the st...
Effect of preoperative anemia on perioperative red blood cell transfusion and prognosis in children with septal defect
Objective To analyze the impact of preoperative anemia on perioperative red blood cell transfusion and prognosis of children undergoing septal defect repair. Methods The medical records of 208 patients under 18 years old...
Effects of autologous platelet-rich plasma combined with negative pressure wound therapy for chronic refractory wounds: a Meta-analysis
Objective To systematically evaluate the therapeutic efficacy of autologous platelet-rich plasma combined with negative pressure wound therapy on chronic refractory wounds, and to provide reference for clinical treatment...
Develop a solid-phase red cell adherence reagent kit for IgG unexpected alloantibody identification
Objective To develop a solid-phase red cell adherence(SPRCA) reagent kit for unexpected alloantibody identification. Methods A solid-phase carrier for bounding red blood cell(RBC) was prepared by coating microstrip with...